Funder
Ministerio de Economía y Competitividad of Spain
Basque Government
Association Belge contre les Maladies Neuro-Musculaires
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Reference83 articles.
1. Bousquet P, Feldman J, Schwarts J. Central cardiovascular effects of alpha-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 1984;230:232-236.
2. Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc. Hematol Agents Med. Chem. 2006;4:17-32.
3. Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clin. Toxicol. 2014;52:454-469.
4. Li, JK. Imidazoline I2 receptors: An update. Pharmacol. Ther. 2017;178:48-56.
5. Fenton, C, Keating, G M, Lyseng-Williamson KA. Moxonidine: a review of its use in essential hypertension. Drugs 2006;6:477-496.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献